CN115282169B - Bufonis venenum extract, and its preparation method and application in preparing medicine for treating heart failure - Google Patents
Bufonis venenum extract, and its preparation method and application in preparing medicine for treating heart failure Download PDFInfo
- Publication number
- CN115282169B CN115282169B CN202211220024.9A CN202211220024A CN115282169B CN 115282169 B CN115282169 B CN 115282169B CN 202211220024 A CN202211220024 A CN 202211220024A CN 115282169 B CN115282169 B CN 115282169B
- Authority
- CN
- China
- Prior art keywords
- extract
- extraction
- treatment
- zeolite powder
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/65—Amphibians, e.g. toads, frogs, salamanders or newts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/54—Improvements relating to the production of bulk chemicals using solvents, e.g. supercritical solvents or ionic liquids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Cardiology (AREA)
- Toxicology (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a preparation method of a toad venom extract, which comprises the following steps: soaking venenum Bufonis powder with softening agent, and standing for use; refluxing in 10-15 times of ethanol solvent, removing ethanol, filtering to obtain first extractive solution, and collecting residue. The venenum bufonis extract is prepared by firstly soaking venenum bufonis powder with a molting agent, adding chitosan into a sodium alginate solution to stir and disperse fully, and matching modified zeolite powder, wherein the dissolubility of the chitosan is dispersed through the sodium alginate, and the modified zeolite powder is matched for modification, so that the dispersity of the zeolite powder is enhanced after the zeolite powder is modified, and the dispersion of the venenum bufonis powder is promoted in the molting agent, thereby being beneficial to the cooperative extraction in the subsequent reflux extraction and supercritical extraction, and improving the extraction efficiency; the conditioning agent is cooperated with lactose and microcrystalline cellulose, thereby being beneficial to the subsequent application in the medicine for treating heart failure.
Description
Technical Field
The invention relates to the technical field of toad venom extracts, and in particular relates to a toad venom extract, a preparation method thereof and application thereof in preparing a medicine for treating heart failure.
Background
Heart failure is a syndrome in which the heart fails to meet the metabolic demand of tissues due to a decrease in cardiac output caused by primary cardiac damage under normal venous return conditions. Clinically, it is characterized by congestion of the pulmonary and/or systemic circulation and insufficient blood perfusion in the tissues, also called congestive heart failure, which is often the terminal stage of heart disease caused by various etiological factors. The concepts of congestive heart failure and cardiac insufficiency are basically the same, but the latter has a broader meaning, including the stage where there has been a reduction in cardiac output but no clinical symptoms have appeared. The invention provides a toad venom extract, a preparation method thereof and application thereof in preparing a medicament for treating heart failure.
Disclosure of Invention
In view of the defects of the prior art, the present invention aims to provide a toad venom extract, a preparation method thereof and an application thereof in preparing a medicament for treating heart failure, so as to solve the problems in the background art.
The technical scheme adopted by the invention for solving the technical problems is as follows:
the invention provides a preparation method of a toad venom extract, which comprises the following steps:
the method comprises the following steps: soaking venenum Bufonis powder with softening agent, and standing for use;
step two: sending into 10-15 weight times of ethanol solvent for refluxing, removing ethanol, filtering to obtain first extractive solution, and collecting residue;
step three: performing supercritical extraction treatment on the filter residue, and obtaining a second extracting solution after extraction is finished;
step four: mixing the first extract and the second extract to obtain an extract, and finally feeding the extract into macroporous resin for elution;
step five: adding 5-10% of regulating agent into Bufonis venenum extract, stirring, and mixing to obtain Bufonis venenum extract.
Preferably, the preparation method of the softening agent comprises the following steps: adding chitosan into 3-6 times of sodium alginate solution, stirring and dispersing fully, then adding modified zeolite powder accounting for 5-10% of the total amount of chitosan, stirring and mixing fully to obtain a softening agent;
the preparation method of the modified zeolite powder comprises the following steps:
feeding the zeolite powder of 150-200 meshes into a heat treatment at 300-400 ℃ for 20-30min, then cooling to room temperature at the speed of 1-3 ℃/min, then feeding into a hydrochloric acid solution of 3-6 times of mass fraction 5-10% to fully disperse, and washing and drying to obtain the modified zeolite powder.
Preferably, the temperature of the infiltration treatment is 40-45 ℃, the treatment rotating speed is 350-450r/min, and the treatment time is 20-30min.
Preferably, the mass fraction of the sodium alginate solution is 10-15%.
Preferably, the extraction time of the reflux is 40-50min; the mass fraction of the refluxing ethanol solvent is 95-97%.
Preferably, the extraction temperature of the supercritical extraction treatment is 38-42 ℃, the extraction pressure is 28-30MPa, and the extraction time is 1-2h.
Preferably, the specific operation steps of the macroporous resin for elution treatment are as follows:
and (3) loading the extracting solution on macroporous resin, removing impurities by elution, then eluting, and finally collecting the eluent, wherein the elution is carried out by adopting an ethanol solution with the mass fraction of 55-60%.
The inventor of the invention finds that the preparation of the toad venom extract is not soaked by the softening agent, the extraction rate of the product is obviously reduced, the modified zeolite powder is not added in the preparation of the softening agent and is replaced by zeolite, the extraction rate of the product is in a trend of being poor, meanwhile, the supercritical extraction treatment is not adopted, the extraction rate of the product is further reduced, and the extraction efficiency of the product can be obviously improved by adopting the soaking treatment of the softening agent and the extraction method of the invention.
Preferably, the rotating speed for uniformly stirring and mixing in the step five is 550-650r/min, and the stirring time is 20-30min; the conditioning treatment agent comprises the following raw materials in parts by weight: 5-10 parts of lactose and 1-5 parts of microcrystalline cellulose.
The invention also provides the toad venom extract prepared by the preparation method of the toad venom extract.
The invention also provides application of the toad venom extract in preparing a medicine for treating heart failure.
Compared with the prior art, the invention has the following beneficial effects:
the venenum bufonis extract is prepared by firstly soaking venenum bufonis powder by using a softening agent, adding chitosan into a sodium alginate solution by using the softening agent, stirring and fully dispersing, and matching modified zeolite powder, wherein the dissolubility of the chitosan is dispersed by using the sodium alginate, and the chitosan is modified by matching the modified zeolite powder, so that the dispersity of the zeolite powder is enhanced after the zeolite powder is modified, and the dispersion of the venenum bufonis powder is promoted in the softening agent, thereby being beneficial to the cooperative extraction in the subsequent reflux extraction and supercritical extraction, and improving the extraction efficiency; the conditioning agent is cooperated with lactose and microcrystalline cellulose, thereby being beneficial to the subsequent application in the medicine for treating heart failure. The extraction method of the invention increases the extraction rate, improves the curative effect and has excellent safety.
The toad venom extract can obviously increase the cell survival rate, obviously improve the oxidation resistance of cells and further greatly improve the heart failure resistance of the medicament.
Detailed Description
The technical solutions in the embodiments of the present invention are clearly and completely described below with reference to specific embodiments, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
The preparation method of the venenum bufonis extract comprises the following steps:
the method comprises the following steps: soaking venenum Bufonis powder with softening agent, and standing by after treatment;
step two: sending into 10-15 times by weight of ethanol solvent for refluxing, removing ethanol after refluxing extraction, filtering to obtain first extractive solution, and collecting residue;
step three: performing supercritical extraction treatment on the filter residue to obtain a second extracting solution after extraction is finished;
step four: mixing the first extract and the second extract to obtain an extract, and finally feeding the extract into macroporous resin for elution;
step five: adding 5-10% of conditioning agent into Bufonis venenum extract, stirring, and mixing to obtain Bufonis venenum extract.
The preparation method of the softening agent in this example is as follows: adding chitosan into 3-6 times of sodium alginate solution, stirring and dispersing fully, then adding modified zeolite powder accounting for 5-10% of the total amount of chitosan, stirring and mixing fully to obtain a softening agent;
the preparation method of the modified zeolite powder comprises the following steps:
and (2) feeding the zeolite powder of 150-200 meshes into a furnace for heat treatment at 300-400 ℃ for 20-30min, then cooling to room temperature at the speed of 1-3 ℃/min, then feeding into a hydrochloric acid solution with the mass fraction of 5-10% which is 3-6 times that of the zeolite powder for full dispersion, and washing and drying the zeolite powder after full dispersion to obtain the modified zeolite powder.
The temperature of the infiltration treatment in the embodiment is 40-45 ℃, the treatment rotating speed is 350-450r/min, and the treatment time is 20-30min.
The mass fraction of the sodium alginate solution in the embodiment is 10-15%.
The reflux extraction time of the embodiment is 40-50min; the mass fraction of the refluxing ethanol solvent is 95-97%.
The supercritical extraction treatment of the embodiment has the extraction temperature of 38-42 ℃, the extraction pressure of 28-30MPa and the extraction time of 1-2h.
The specific operation steps of the macroporous resin elution treatment in this example are as follows:
and (3) sampling the extracting solution on macroporous resin, removing impurities by adopting elution, then performing elution, and finally collecting the eluent, wherein the elution is performed by adopting an ethanol solution with the mass fraction of 55-60%.
In the fifth step of this embodiment, the rotation speed for stirring and mixing uniformly is 550-650r/min, and the stirring time is 20-30min; the conditioning treatment agent comprises the following raw materials in parts by weight: 5-10 parts of lactose and 1-5 parts of microcrystalline cellulose.
The venenum bufonis extract obtained by the preparation method of the venenum bufonis extract of the embodiment is provided.
The application of the venenum bufonis extract in preparing the medicine for treating heart failure is disclosed.
Example 1.
The preparation method of the venenum bufonis extract comprises the following steps:
the method comprises the following steps: soaking venenum Bufonis powder with softening agent, and standing for use;
step two: sending into 10 weight times of ethanol solvent for refluxing, removing ethanol, filtering to obtain first extractive solution, and collecting residue;
step three: performing supercritical extraction treatment on the filter residue, and obtaining a second extracting solution after extraction is finished;
step four: mixing the first extract and the second extract to obtain an extract, and finally feeding the extract into macroporous resin for elution;
step five: adding 5% of regulating agent into Bufonis venenum extract, stirring, and mixing to obtain Bufonis venenum extract.
The preparation method of the softening agent in this embodiment comprises: adding chitosan into 3 times of sodium alginate solution, stirring and dispersing fully, then adding modified zeolite powder accounting for 5% of the total amount of chitosan, stirring and mixing fully to obtain a softening agent;
the preparation method of the modified zeolite powder comprises the following steps:
and (2) feeding the 150-mesh zeolite powder into a 300 ℃ for heat treatment for 20min, then cooling to room temperature at the speed of 1 ℃/min, then feeding into a 3-time hydrochloric acid solution with the mass fraction of 5% for full dispersion, and washing and drying to obtain the modified zeolite powder.
The temperature of the infiltration treatment in the embodiment is 40 ℃, the treatment rotating speed is 350r/min, and the treatment time is 20min.
The mass fraction of the sodium alginate solution in this example was 10%.
The reflux extraction time of this example was 40min; the mass fraction of the refluxing ethanol solvent is 95%.
The supercritical extraction temperature of the supercritical fluid extraction treatment in this example was 38 ℃, the extraction pressure was 28MPa, and the extraction time was 1h.
The specific operation steps of the macroporous resin for elution treatment in this embodiment are as follows:
and (3) sampling the extracting solution on macroporous resin, removing impurities by adopting elution, then eluting, and finally collecting eluent, wherein the elution is carried out by adopting an ethanol solution with the mass fraction of 55%.
In the fifth step of this embodiment, the rotation speed of stirring and mixing uniformly is 550r/min, and the stirring time is 20min; the conditioning treatment agent comprises the following raw materials in parts by weight: 5 parts of lactose and 1 part of microcrystalline cellulose.
The venenum bufonis extract obtained by the preparation method of the venenum bufonis extract of the embodiment is provided.
The application of the venenum bufonis extract in preparing the medicine for treating heart failure is disclosed.
Example 2.
The preparation method of the venenum bufonis extract comprises the following steps:
the method comprises the following steps: soaking venenum Bufonis powder with softening agent, and standing for use;
step two: sending into 15 weight times of ethanol solvent for refluxing, removing ethanol after refluxing extraction, filtering to obtain first extractive solution, and collecting residue;
step three: performing supercritical extraction treatment on the filter residue to obtain a second extracting solution after extraction is finished;
step four: mixing the first extract and the second extract to obtain an extract, and finally feeding the extract into macroporous resin for elution;
step five: adding 10% of conditioning agent into Bufonis venenum extract, stirring, and mixing to obtain Bufonis venenum extract.
The preparation method of the softening agent in this example is as follows: adding chitosan into 6 times of sodium alginate solution, stirring and dispersing fully, then adding modified zeolite powder accounting for 10% of the total amount of the chitosan, stirring and mixing fully to obtain a softening agent;
the preparation method of the modified zeolite powder comprises the following steps:
and (2) feeding the zeolite powder of 200 meshes into a reactor at 400 ℃ for heat treatment for 30min, then cooling to room temperature at the speed of 3 ℃/min, then feeding into a hydrochloric acid solution with the mass fraction of 10% which is 6 times that of the zeolite powder for full dispersion, and washing and drying to obtain the modified zeolite powder.
The temperature of the infiltration treatment in the embodiment is 45 ℃, the treatment rotating speed is 450r/min, and the treatment time is 30min.
The mass fraction of the sodium alginate solution in this example was 15%.
The reflux extraction time in this example was 50min; the mass fraction of the refluxing ethanol solvent is 97%.
The supercritical extraction of this example was carried out at 42 deg.C under 30MPa for 2h.
The specific operation steps of the macroporous resin elution treatment in this example are as follows:
and (3) loading the extracting solution on macroporous resin, removing impurities by elution, then eluting, and finally collecting the eluent, wherein the elution is carried out by adopting an ethanol solution with the mass fraction of 60%.
In the fifth step of this embodiment, the rotation speed for stirring and mixing uniformly is 650r/min, and the stirring time is 30min; the conditioning treatment agent comprises the following raw materials in parts by weight: 10 parts of lactose and 5 parts of microcrystalline cellulose.
The preparation method of the venenum bufonis extract of the embodiment is used for preparing the venenum bufonis extract.
The application of the toad venom extract in preparing the medicine for treating heart failure is disclosed in the embodiment.
Example 3.
The preparation method of the venenum bufonis extract comprises the following steps:
the method comprises the following steps: soaking venenum Bufonis powder with softening agent, and standing by after treatment;
step two: sending into 12 weight times of ethanol solvent for refluxing, removing ethanol after refluxing extraction, filtering to obtain first extractive solution, and collecting residue;
step three: performing supercritical extraction treatment on the filter residue to obtain a second extracting solution after extraction is finished;
step four: mixing the first extract and the second extract to obtain an extract, and finally feeding the extract into macroporous resin for elution;
step five: adding 7.5% of regulating agent into Bufonis venenum extract, stirring, and mixing to obtain Bufonis venenum extract.
The preparation method of the softening agent in this example is as follows: adding chitosan into 4.5 times of sodium alginate solution, stirring and dispersing fully, then adding modified zeolite powder accounting for 7.5% of the total amount of the chitosan, stirring and mixing fully to obtain a softening agent;
the preparation method of the modified zeolite powder comprises the following steps:
and (2) feeding the 175-mesh zeolite powder to 350 ℃ for heat treatment for 25min, then cooling to room temperature at the speed of 2 ℃/min, then feeding the zeolite powder to 4.5 times of hydrochloric acid solution with the mass fraction of 7.5% for full dispersion, and washing and drying the zeolite powder to obtain the modified zeolite powder.
The temperature of the infiltration treatment in this embodiment is 42 ℃, the treatment rotation speed is 390r/min, and the treatment time is 25min.
The mass fraction of the sodium alginate solution in this example was 12.5%.
The extraction time of the reflux in this example was 45min; the mass fraction of the refluxing ethanol solvent is 96%.
The supercritical extraction temperature of the supercritical fluid extraction treatment in this example was 40 ℃, the extraction pressure was 29MPa, and the extraction time was 1.5h.
The specific operation steps of the macroporous resin elution treatment in this example are as follows:
and (3) sampling the extracting solution on macroporous resin, removing impurities by adopting elution, then eluting, and finally collecting the eluent, wherein the elution is carried out by adopting an ethanol solution with the mass fraction of 59%.
In the fifth step of this embodiment, the rotation speed for stirring and mixing uniformly is 600r/min, and the stirring time is 25min; the conditioning treatment agent comprises the following raw materials in parts by weight: 7.5 parts of lactose and 3 parts of microcrystalline cellulose.
The preparation method of the venenum bufonis extract of the embodiment is used for preparing the venenum bufonis extract.
The application of the toad venom extract in preparing the medicine for treating heart failure is disclosed in the embodiment.
Example 4.
The preparation method of the venenum bufonis extract comprises the following steps:
the method comprises the following steps: soaking venenum Bufonis powder with softening agent, and standing by after treatment;
step two: sending into 12 weight times of ethanol solvent for refluxing, removing ethanol after refluxing extraction, filtering to obtain first extractive solution, and collecting residue;
step three: performing supercritical extraction treatment on the filter residue to obtain a second extracting solution after extraction is finished;
step four: mixing the first extract and the second extract to obtain an extract, and finally feeding the extract into macroporous resin for elution;
step five: adding 6% of regulating agent into Bufonis venenum extract, stirring, and mixing to obtain Bufonis venenum extract.
The preparation method of the softening agent in this embodiment comprises: adding chitosan into 4 times of sodium alginate solution, stirring and dispersing fully, then adding modified zeolite powder accounting for 6% of the total amount of the chitosan, stirring and mixing fully to obtain a softening agent;
the preparation method of the modified zeolite powder comprises the following steps:
and (2) feeding the 160-mesh zeolite powder to 320 ℃ for heat treatment for 22min, then cooling to room temperature at the speed of 2 ℃/min, then feeding the zeolite powder to 4 times of hydrochloric acid solution with the mass fraction of 6% for full dispersion, and washing and drying the zeolite powder to obtain the modified zeolite powder.
The temperature of the infiltration treatment in the embodiment is 42 ℃, the treatment rotating speed is 360r/min, and the treatment time is 22min.
The mass fraction of the sodium alginate solution in this example was 12%.
The extraction time of the reflux in this example was 42min; the mass fraction of the refluxing ethanol solvent is 96%.
The supercritical extraction treatment of this example was carried out at an extraction temperature of 39 deg.C, an extraction pressure of 29MPa, and an extraction time of 1.2h.
The specific operation steps of the macroporous resin elution treatment in this example are as follows:
and (3) loading the extracting solution on macroporous resin, removing impurities by elution, then eluting, and finally collecting the eluent, wherein the elution is carried out by adopting an ethanol solution with the mass fraction of 58%.
In the fifth step of this embodiment, the rotation speed of stirring and mixing uniformly is 570r/min, and the stirring time is 22min; the conditioning treatment agent comprises the following raw materials in parts by weight: 6 parts of lactose and 2 parts of microcrystalline cellulose.
The venenum bufonis extract obtained by the preparation method of the venenum bufonis extract of the embodiment is provided.
The application of the venenum bufonis extract in preparing the medicine for treating heart failure is disclosed.
Comparative example 1.
Unlike example 3, no treatment with a softener was used.
Comparative example 2.
The difference from example 3 is that no modified zeolite powder was added in the preparation of the flexibilizer.
Comparative example 3.
The difference from example 3 is that the modified zeolite powder is replaced by zeolite.
Comparative example 4.
Unlike example 3, the supercritical extraction treatment was not employed.
According to the invention, the extraction rate of bufogenin components is tested, and the performances of the extraction rates of the bufogenin components of examples 1-4 and comparative examples 1-4 are tested as follows:
as can be seen from comparative examples 1 to 4 and examples 1 to 4;
the preparation of the venenum bufonis extract is not subjected to mollifuge infiltration treatment, the extraction rate of a product is remarkably reduced, modified zeolite powder is not added in the preparation of the mollifuge and is replaced by zeolite, the extraction rate of the product tends to be poor, meanwhile, supercritical extraction treatment is not adopted, and the extraction rate of the product is further reduced.
The innovation points of the invention are as follows: the venenum bufonis extract is prepared by matching modified zeolite powder, wherein the solubility of chitosan is dispersed through sodium alginate, and the chitosan is modified and prepared through matching modified zeolite powder, the dispersity of the zeolite powder is enhanced after the zeolite powder is modified, and then the dispersing of the venenum bufonis powder is promoted in the softening agent, so that the synergistic extraction in subsequent reflux extraction and supercritical extraction is facilitated, and the extraction efficiency is improved; the conditioning agent is cooperated with lactose and microcrystalline cellulose, thereby being beneficial to the subsequent application in the medicine for treating heart failure.
It will be evident to those skilled in the art that the invention is not limited to the details of the foregoing illustrative embodiments, and that the present invention may be embodied in other specific forms without departing from the spirit or essential attributes thereof. The present embodiments are therefore to be considered in all respects as illustrative and not restrictive, the scope of the invention being indicated by the appended claims rather than by the foregoing description, and all changes which come within the meaning and range of equivalency of the claims are therefore intended to be embraced therein.
Furthermore, it should be understood that although the present description refers to embodiments, not every embodiment may contain only a single embodiment, and such description is for clarity only, and those skilled in the art should integrate the description, and the embodiments may be combined as appropriate to form other embodiments understood by those skilled in the art.
Claims (1)
1. The preparation method of the toad venom extract is characterized by comprising the following steps of:
the method comprises the following steps: soaking venenum Bufonis powder with softening agent, and standing for use;
step two: sending into 10-15 times by weight of ethanol solvent for refluxing, removing ethanol after refluxing extraction, filtering to obtain first extractive solution, and collecting residue;
step three: performing supercritical extraction treatment on the filter residue, and obtaining a second extracting solution after extraction is finished;
step four: mixing the first extract and the second extract to obtain an extract, and finally feeding the extract into macroporous resin for elution;
step five: adding 5-10% of regulating treatment agent into the Bufonis venenum extract, stirring and mixing to obtain Bufonis venenum extract;
the preparation method of the softening agent comprises the following steps: adding chitosan into 3-6 times of sodium alginate solution, stirring and dispersing fully, then adding modified zeolite powder accounting for 5-10% of the total amount of chitosan, stirring and mixing fully to obtain a softening agent;
the preparation method of the modified zeolite powder comprises the following steps:
feeding zeolite powder of 150-200 meshes into a heat treatment at 300-400 ℃ for 20-30min, cooling to room temperature at the speed of 1-3 ℃/min, then feeding into hydrochloric acid solution of which the mass fraction is 5-10% and is 3-6 times that of the zeolite powder, fully dispersing, washing with water, and drying to obtain modified zeolite powder;
the temperature of the infiltration treatment is 40-45 ℃, the treatment rotating speed is 350-450r/min, and the treatment time is 20-30min;
the mass fraction of the sodium alginate solution is 10-15%;
the reflux extraction time is 40-50min; the mass fraction of the refluxing ethanol solvent is 95-97%;
the extraction temperature of the supercritical extraction treatment is 38-42 ℃, the extraction pressure is 28-30MPa, and the extraction time is 1-2h; the specific operation steps of the macroporous resin for elution treatment are as follows:
loading the extract on macroporous resin, removing impurities by elution, then eluting, and finally collecting the eluent, wherein the elution is performed by adopting an ethanol solution with the mass fraction of 55-60%;
in the fifth step, the rotating speed for stirring and mixing uniformly is 550-650r/min, and the stirring time is 20-30min; the conditioning treatment agent comprises the following raw materials in parts by weight: 5-10 parts of lactose and 1-5 parts of microcrystalline cellulose.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202211220024.9A CN115282169B (en) | 2022-10-08 | 2022-10-08 | Bufonis venenum extract, and its preparation method and application in preparing medicine for treating heart failure |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202211220024.9A CN115282169B (en) | 2022-10-08 | 2022-10-08 | Bufonis venenum extract, and its preparation method and application in preparing medicine for treating heart failure |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN115282169A CN115282169A (en) | 2022-11-04 |
| CN115282169B true CN115282169B (en) | 2023-01-24 |
Family
ID=83833098
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202211220024.9A Active CN115282169B (en) | 2022-10-08 | 2022-10-08 | Bufonis venenum extract, and its preparation method and application in preparing medicine for treating heart failure |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN115282169B (en) |
Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101669970A (en) * | 2009-09-21 | 2010-03-17 | 宁波大学 | Method for microwave extracting fat-soluble toad venom by using skin of Bufo bufo gargarizans |
| CN102210711A (en) * | 2011-06-02 | 2011-10-12 | 陈彦 | Senso fat-soluble extract dry powder inhalation, preparation method and application thereof |
| CN102526110A (en) * | 2010-12-17 | 2012-07-04 | 中国人民解放军第三〇二医院 | Venenum bufonis powder injection for cardiotonic emergency treatment and preparation method thereof |
| CN103191132A (en) * | 2013-04-23 | 2013-07-10 | 山东中医药大学 | Preparation method for extracting high-purity resibufogenin from venenum bufonis |
| CN104840488A (en) * | 2015-05-13 | 2015-08-19 | 内蒙古康恩贝药业有限公司 | Traditional Chinese medicine toad venom dissimlar extract and preparation method thereof |
| CN105769927A (en) * | 2016-03-17 | 2016-07-20 | 南京多宝生物科技有限公司 | Venenum Bufonis extraction method and Venenum Bufonis product |
| CN109187802A (en) * | 2018-10-18 | 2019-01-11 | 广州悦康生物制药有限公司 | The detection method of dried venom of toads content in pill for promoting coronary circulation is concentrated |
| CN109331046A (en) * | 2018-12-17 | 2019-02-15 | 南京中医药大学 | A kind of processing and treating method of the dried venom of toads |
| CN114920795A (en) * | 2022-05-12 | 2022-08-19 | 赣江中药创新中心 | Preparation method of dried toad skin bufogenin lactone component |
-
2022
- 2022-10-08 CN CN202211220024.9A patent/CN115282169B/en active Active
Patent Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101669970A (en) * | 2009-09-21 | 2010-03-17 | 宁波大学 | Method for microwave extracting fat-soluble toad venom by using skin of Bufo bufo gargarizans |
| CN102526110A (en) * | 2010-12-17 | 2012-07-04 | 中国人民解放军第三〇二医院 | Venenum bufonis powder injection for cardiotonic emergency treatment and preparation method thereof |
| CN102210711A (en) * | 2011-06-02 | 2011-10-12 | 陈彦 | Senso fat-soluble extract dry powder inhalation, preparation method and application thereof |
| CN103191132A (en) * | 2013-04-23 | 2013-07-10 | 山东中医药大学 | Preparation method for extracting high-purity resibufogenin from venenum bufonis |
| CN104840488A (en) * | 2015-05-13 | 2015-08-19 | 内蒙古康恩贝药业有限公司 | Traditional Chinese medicine toad venom dissimlar extract and preparation method thereof |
| CN105769927A (en) * | 2016-03-17 | 2016-07-20 | 南京多宝生物科技有限公司 | Venenum Bufonis extraction method and Venenum Bufonis product |
| CN109187802A (en) * | 2018-10-18 | 2019-01-11 | 广州悦康生物制药有限公司 | The detection method of dried venom of toads content in pill for promoting coronary circulation is concentrated |
| CN109331046A (en) * | 2018-12-17 | 2019-02-15 | 南京中医药大学 | A kind of processing and treating method of the dried venom of toads |
| CN114920795A (en) * | 2022-05-12 | 2022-08-19 | 赣江中药创新中心 | Preparation method of dried toad skin bufogenin lactone component |
Non-Patent Citations (5)
| Title |
|---|
| 不同提取方法对蟾酥有效成分的影响;袁旭江 等;《上海中医药大学学报》;20080925;第22卷(第5期);摘要，第1-2节 * |
| 脂溶性蟾毒配基的纯化工艺研究;王艳华 等;《中国民族民间医药》;20160715;第25卷(第13期);第15-17+20页 摘要，第1-3节 * |
| 蟾酥化学成分及抗肿瘤作用研究进展;邓莎 等;《中成药》;20220331;第44卷(第3期);第884-890页 * |
| 蟾酥治疗心血管疾病的药理研究进展;姜艳等;《天津中医药大学学报》;20120915(第03期);第187-189页 * |
| 蟾酥类制剂的研究进展;袁佳妮等;《陕西中医》;20180905(第09期);第1316-1318页 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN115282169A (en) | 2022-11-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN107011460B (en) | Method for extracting beta-glucan by taking highland barley bran as raw material | |
| CN115282169B (en) | Bufonis venenum extract, and its preparation method and application in preparing medicine for treating heart failure | |
| WO2021042754A1 (en) | Industrial production method for extracting tea polyphenols from green tea | |
| CN106046075A (en) | Method for extracting stevioside from stevia rebaudiana leaves | |
| CN107260614A (en) | It is a kind of to strengthen the facial mask of oxidation resistance | |
| CN104558224B (en) | Method for preparing astragalus polysaccharide and water reservoir gel from astragalus residues | |
| CN112029009B (en) | Preparation method of pitaya flower polysaccharide | |
| CN103919818B (en) | A kind of preparation method of nanoscale Cordycepses microcapsule | |
| CN115227744B (en) | Lung-tonifying and blood-activating capsule and preparation method thereof | |
| CN116407483A (en) | Formula and preparation method of oil-control moisturizing facial cleanser | |
| CN112569287B (en) | Anti-allergy itching-relieving plant composition and preparation method and application thereof | |
| CN107095893A (en) | A kind of extracting method of Root of Dunn Tongoloa active material and its application | |
| CN117137036A (en) | Processing method based on soybean protein peptide | |
| CN112843140A (en) | Medicine for treating thirst and conjunctival congestion caused by diabetes, preparation method and application | |
| CN217889494U (en) | Device for boiling and washing gold powder | |
| CN116763838B (en) | Pudi blue anti-inflammatory tablet and preparation method thereof | |
| CN111303109B (en) | Method for extracting anthocyanin from fresh tea leaves | |
| CN106946999A (en) | A kind of discoloration method of rough gentian grass polysaccharide | |
| CN108411632A (en) | A kind of preparation method of environment-friendly type cotton finishing agent | |
| CN107549810A (en) | A kind of Co-Q10 vitamin E soft capsule and preparation method thereof | |
| CN102475754B (en) | Shenkang soft capsule for treating chronic renal failure and preparation method of Shenkang soft capsule | |
| CN114875701B (en) | Processing method of cotton pulp for vulcanized fiber paper | |
| CN113024689B (en) | Method for controlling molecular weight of dalteparin sodium | |
| CN107638429A (en) | A kind of medicine for treating rhinitis and preparation method thereof | |
| CN116987035A (en) | Preparation process of functional anserine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |